As of February 18, 2019, Eckert & Ziegler BEBIG S.A. was acquired by Eckert & Ziegler Strahlen- und Medizintechnik AG. Eckert & Ziegler BEBIG S.A. through its subsidiaries, develops, manufactures, and sells radiation equipment and related products based on isotope technology. It offers IsoSeed for the treatment of prostate cancer; Mick TP/TPV Applicator System, a brachytherapy implantation technique that allows for seed placement adjustments during implant to adapt changes of prostate size and position; IsoCord, a seed chain that provides radiation protection; IsoStrand, a seed chain that consists of 10 IsoSeeds with 1.0 cm center-to-center spacing for protection against radiation; and needles for LDR brachytherapy. The company also offers IsoSeed I25.S17plus loose seeds for brain tumor treatment; SagiNova and MultiSource HDR (high dose rate) afterloader systems for the HDR brachytherapy applications; SagiPlan software for HDR treatment plans; and Cobalt-60 for various HDR brachytherapy treatments. In addition, it offers gynecological and rectal HDR applicators and accessories; CT/MR contour prostate template sets; tongue and mouth, and nasopharynx applicator sets; breast bridge sets; esophagus applicator and bronchus intraluminal sets; Harrison-Anderson-Mick applicators; and Valencia applicator sets. Further, the company provides products for the temporary brachytherapy of eye cancers, including Ru-106 eye applicators for the treatment of uveal melanoma and retinoblastoma; and I-125 ophthalmic seeds for use in COMS eye applicators to treat eye tumors, such as uveal melanomas and retinoblastomas, as well as offers radiotherapy accessories. It markets and sells its products to oncologists, radiologists, urologists, and medical physicists through a network of distributors and agents worldwide. The company was formerly known as International Brachytherapy s.a. and changed its name to Eckert & Ziegler BEBIG S.A. in June 2011. The company was founded in 1996 and is headquartered in Seneffe, Belgium.